Development of a high-throughput screening system for identification of novel reagents regulating DNA damage in human dermal fibroblasts

Ultraviolet (UV) radiation is a major inducer of skin aging and accumulated exposure to UV radiation increases DNA damage in skin cells, including dermal fibroblasts. In the present study, we developed a novel DNA repair regulating material discovery (DREAM) system for the high-throughput screening...

Full description

Saved in:
Bibliographic Details
Main Authors: Bae Seunghee, An In-Sook, An Sungkwan
Format: Article
Language:English
Published: Sciendo 2015-09-01
Series:Acta Pharmaceutica
Subjects:
Online Access:https://doi.org/10.1515/acph-2015-0025
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832572492478152704
author Bae Seunghee
An In-Sook
An Sungkwan
author_facet Bae Seunghee
An In-Sook
An Sungkwan
author_sort Bae Seunghee
collection DOAJ
description Ultraviolet (UV) radiation is a major inducer of skin aging and accumulated exposure to UV radiation increases DNA damage in skin cells, including dermal fibroblasts. In the present study, we developed a novel DNA repair regulating material discovery (DREAM) system for the high-throughput screening and identification of putative materials regulating DNA repair in skin cells. First, we established a modified lentivirus expressing the luciferase and hypoxanthine phosphoribosyl transferase (HPRT) genes. Then, human dermal fibroblast WS-1 cells were infected with the modified lentivirus and selected with puromycin to establish cells that stably expressed luciferase and HPRT (DREAM-F cells). The first step in the DREAM protocol was a 96-well-based screening procedure, involving the analysis of cell viability and luciferase activity after pretreatment of DREAM-F cells with reagents of interest and post-treatment with UVB radiation, and vice versa. In the second step, we validated certain effective reagents identified in the first step by analyzing the cell cycle, evaluating cell death, and performing HPRT-DNA sequencing in DREAM-F cells treated with these reagents and UVB. This DREAM system is scalable and forms a time-saving high-throughput screening system for identifying novel anti-photoaging reagents regulating DNA damage in dermal fibroblasts.
format Article
id doaj-art-85addfdc049343d5b7acc7971b1bfc5d
institution Kabale University
issn 1846-9558
language English
publishDate 2015-09-01
publisher Sciendo
record_format Article
series Acta Pharmaceutica
spelling doaj-art-85addfdc049343d5b7acc7971b1bfc5d2025-02-02T09:57:48ZengSciendoActa Pharmaceutica1846-95582015-09-0165333134110.1515/acph-2015-0025acph-2015-0025Development of a high-throughput screening system for identification of novel reagents regulating DNA damage in human dermal fibroblastsBae Seunghee0An In-Sook1An Sungkwan2Korea Institute for Skin and Clinical Sciences, Konkuk University, 120 Neungdong-ro, Gwangjin-gu, Seoul 143-701, Republic of KoreaKorea Institute for Skin and Clinical Sciences, Konkuk University, 120 Neungdong-ro, Gwangjin-gu, Seoul 143-701, Republic of KoreaKorea Institute for Skin and Clinical Sciences, Konkuk University, 120 Neungdong-ro, Gwangjin-gu, Seoul 143-701, Republic of KoreaUltraviolet (UV) radiation is a major inducer of skin aging and accumulated exposure to UV radiation increases DNA damage in skin cells, including dermal fibroblasts. In the present study, we developed a novel DNA repair regulating material discovery (DREAM) system for the high-throughput screening and identification of putative materials regulating DNA repair in skin cells. First, we established a modified lentivirus expressing the luciferase and hypoxanthine phosphoribosyl transferase (HPRT) genes. Then, human dermal fibroblast WS-1 cells were infected with the modified lentivirus and selected with puromycin to establish cells that stably expressed luciferase and HPRT (DREAM-F cells). The first step in the DREAM protocol was a 96-well-based screening procedure, involving the analysis of cell viability and luciferase activity after pretreatment of DREAM-F cells with reagents of interest and post-treatment with UVB radiation, and vice versa. In the second step, we validated certain effective reagents identified in the first step by analyzing the cell cycle, evaluating cell death, and performing HPRT-DNA sequencing in DREAM-F cells treated with these reagents and UVB. This DREAM system is scalable and forms a time-saving high-throughput screening system for identifying novel anti-photoaging reagents regulating DNA damage in dermal fibroblasts.https://doi.org/10.1515/acph-2015-0025human dermal fibroblastsdna damagehigh-throughput screeningaging
spellingShingle Bae Seunghee
An In-Sook
An Sungkwan
Development of a high-throughput screening system for identification of novel reagents regulating DNA damage in human dermal fibroblasts
Acta Pharmaceutica
human dermal fibroblasts
dna damage
high-throughput screening
aging
title Development of a high-throughput screening system for identification of novel reagents regulating DNA damage in human dermal fibroblasts
title_full Development of a high-throughput screening system for identification of novel reagents regulating DNA damage in human dermal fibroblasts
title_fullStr Development of a high-throughput screening system for identification of novel reagents regulating DNA damage in human dermal fibroblasts
title_full_unstemmed Development of a high-throughput screening system for identification of novel reagents regulating DNA damage in human dermal fibroblasts
title_short Development of a high-throughput screening system for identification of novel reagents regulating DNA damage in human dermal fibroblasts
title_sort development of a high throughput screening system for identification of novel reagents regulating dna damage in human dermal fibroblasts
topic human dermal fibroblasts
dna damage
high-throughput screening
aging
url https://doi.org/10.1515/acph-2015-0025
work_keys_str_mv AT baeseunghee developmentofahighthroughputscreeningsystemforidentificationofnovelreagentsregulatingdnadamageinhumandermalfibroblasts
AT aninsook developmentofahighthroughputscreeningsystemforidentificationofnovelreagentsregulatingdnadamageinhumandermalfibroblasts
AT ansungkwan developmentofahighthroughputscreeningsystemforidentificationofnovelreagentsregulatingdnadamageinhumandermalfibroblasts